Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huijie Wang
Observed name:
王惠杰
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Luoyang Central Hospital Affiliated to Zhengzhou University
ORCID:
0000-0002-1014-6885
Observed ORCID:
0000-0002-1014-6885
OpenAlex ID:
A5020608637
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2022
·
Xin Liu
, Shiyu Jiang
, et al.
·
Clinical Cancer Research
·
38
B3GNT3 facilitates NFKB2 processing and non-canonical NF-κB activation to drive lung adenocarcinoma progression
2026
·
Ying Lin
, Yao Zhang
, et al.
·
Cellular Oncology
·
1
Supplementary Data TS1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2025
·
Xin Liu
, Shiyu Jiang
, et al.
PDF
Figure S1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2025
·
Xin Liu
, Shiyu Jiang
, et al.
PDF
Effects of Qixuekang oral liquid in leukopenia during chemotherapy and radiotherapy in patients with malignant tumors: A randomized, double-blind, placebo-controlled, multicenter study
2025
·
Yafang Cai
, Peng Xue
, et al.
·
Journal of Traditional Chinese Medical Sciences
Data from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
Supplementary Data TS1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
Figure S1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
PDF
Data from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
Clinical analysis of eleven adult patients with inflammatory myofibroblastic tumor
2018
·
张晓伟
, 王惠杰
·
DOAJ (DOAJ: Directory of Open Access Journals)
Pegylated liposomal doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma
2017
·
刘 欣
, 张晓伟
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
11
Citation count:
39
H-index:
1
I10-index:
1
Year
Topic
Type